You just read:

SELLAS Life Sciences Group Signs Exclusive License Agreement for Global Rights on Development and Commercialization of WT1 Cancer Vaccine with Memorial Sloan Kettering Cancer Center

News provided by

SELLAS Life Sciences Group

Sep 04, 2014, 02:43 ET